---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-004295"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2023-02-21T23:59:59+00:00"
generated_at: "2026-06-19T07:38:26.921923+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medifast Q4 revenue down 10.7% to $337.2M; guides Q1 revenue $300-320M

## Summary
- Q4 GAAP EPS $2.41, adjusted EPS $3.70; net income $26.5M vs $34.0M YoY.
- Full-year 2022 revenue up 4.8% to $1.6B; GAAP EPS $12.73, adjusted EPS $14.50.
- Active earning OPTA VIA Coaches 60,900 (+1.8% YoY); revenue per coach $5,538 (-12.4%).
- Q1 2023 guidance: revenue $300-320M, diluted EPS $1.75-2.40; assumes 26-27% tax rate.
- Cash $87.7M, no debt; quarterly dividend of $1.64/share paid Feb 7, 2023.

## SEC filing metadata
- accession: 0001628280-23-004295
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2023-02-21T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828023004295/0001628280-23-004295-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828023004295/med-20230221.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-004295
- JSON: https://secwatch.observer/filing/0001628280-23-004295.json
- Plain text: https://secwatch.observer/filing/0001628280-23-004295.txt

## Key facts
- Earnings Releases
  MEDIFAST INC reported the fiscal year ended December 31, 2022 results: revenue $1.6 billion, net income $143.6 million, EPS $12.73 per diluted share. Guidance reaffirmed.
  - Period: the fiscal year ended December 31, 2022
  - Revenue: $1.6 billion
  - Net income: $143.6 million
  - EPS: $12.73 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: For the fiscal year ended December 31, 2022, revenue increased 4.8% to $1.6 billion compared to revenue of $1.5 billion in 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/910329/000162828023004295/0001628280-23-004295-index.htm
- Earnings Releases
  MEDIFAST INC reported the fourth quarter ended December 31, 2022 results: revenue $337.2 million, net income $26.5 million, EPS $2.41 per diluted share.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $337.2 million
  - Net income: $26.5 million
  - EPS: $2.41 per diluted share
  - Result: reported results
  source text: one of the fastest-growing health and wellness communities, OPTA VIA® , today reported results for the fourth quarter ended December 31, 2022. Fourth Quarter 2022 • Revenue of $337.2 million, with revenue per active earning coach of $5,538 • Independent active earning OPTA VIA Coaches of 60,900 • Net income of $26.5 million (non-GAAP adjusted net income of $40.6
  evidence_url: https://www.sec.gov/Archives/edgar/data/910329/000162828023004295/0001628280-23-004295-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.